Literature DB >> 977565

Purification of a glycoprotein from mouse ascites fluid by immunoaffinity chromatography which is related to the major glycoprotein of murine leukemia viruses. Immunologic and structural comparison with purified viral glycoproteins.

S J Kennel.   

Abstract

Proteins immunologically related to the major glycoprotein from murine leukemia viruses, gp70, are expressed in the tissue and body fluids of unmanipulated mice in the absence of virus particle production. Cross-reactive gp70 was isolated from ascites fluid of NZB and (NZB X NZW)F1 mice utilizing immunoaffinity chromatography. An enriched antibody preparation bound to Sepharose was used as an immunosorbent to purify gp70 over 600-fold in one step with a 30% recovery. The gp70s from ascites fluid were compared with gp70s purified from laboratory virus strains Friend, Rauscher, Moloney, and Scripps leukemia viruses. Direct antibody binding studies showed that the viral gp70s were more closely related to each other than to the gp70s from ascites fluid. Furthermore, the gp70s from ascites fluid were more reactive with antibody to xenotropic virus than were the gp70s from the laboratory viruses tested. Tryptic peptide map analysis of radioiodinated proteins showed that gp70 from Scripps virus is closely related to gp70 from Moloney virus in primary structure and less closely related structurally to gp70 from Rauscher virus and gp70 from NZB ascites fluid.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 977565

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants.

Authors:  J H Elder; J W Gautsch; F C Jensen; R A Lerner; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

2.  Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide.

Authors:  N Green; T M Shinnick; O Witte; A Ponticelli; J G Sutcliffe; R A Lerner
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

3.  Envelope polypeptides of Friend leukemia virus: purification and structural analysis.

Authors:  J Schneider; H Falk; G Hunsmann
Journal:  J Virol       Date:  1980-02       Impact factor: 5.103

4.  Analysis of proteins of mouse sarcoma pseudotype viruses: type-specific radioimmunoassay for ecotropic virus p30's.

Authors:  S J Kennel; R W Tennant
Journal:  J Virol       Date:  1979-06       Impact factor: 5.103

5.  Isolation and comparison of murine leukemia virus-related glycoproteins from AKR and New Zealand mice.

Authors:  S J Kennel
Journal:  J Virol       Date:  1977-04       Impact factor: 5.103

6.  Dog and human acid beta-D-galactosidases are structurally similar.

Authors:  J J Hubert; J S O'Brien
Journal:  Biochem J       Date:  1983-08-01       Impact factor: 3.857

7.  Complete amino acid sequence and glycosylation sites of glycoprotein gp71A of Friend murine leukemia virus.

Authors:  R Chen
Journal:  Proc Natl Acad Sci U S A       Date:  1982-10       Impact factor: 11.205

8.  Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70.

Authors:  C L Reading; K W Brunson; M Torrianni; G L Nicolson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-10       Impact factor: 11.205

9.  Expression of AKR murine leukemia virus gp71-like and BALB(X) gp-71-like antigens in normal mouse tissues in the absence of overt virus expression.

Authors:  P R McClintock; J N Ihle; D R Joseph
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

10.  Syngeneic immune response to rat tracheal epithelial cells transformed in vitro by N-methyl-N-nitro-N-nitrosoguanidine.

Authors:  G R Braslawsky; V Steele; S J Kennel; P Nettesheim
Journal:  Br J Cancer       Date:  1981-08       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.